Aroa has third straight positive cash flow quarter
Aroa Biosurgery recorded its third consecutive quarter of positive net cash flow since listing on the ASX in July 2020 and has reaffirmed FY26 revenue guidance.
Stockhead
StockTake: DY6 Metals
DY6 Metals has kicked off a soil sampling program to guide maiden auger drilling at its Central rutile project in Cameroon.
European drug makers spared supersized Trump tariff
European pharma companies are breathing a sigh of relief after the Trump administration posed a 15pc tariff, rather than 200pc.
PCL upgrades resource at Oryx prospect
A study has upgraded the prospective resource at Pancontinental Energy’s Oryx prospect by 53% to 815MMbbl while boosting success odds to 26.2%.
More Stories
StockTake: Greenvale Energy
Tylah Tully looks at a multi-thousand metre Greenvale Energy drill campaign now underway at its Oasis uranium project in Queensland.
PNN secures Pocitos water drilling approval
Power Minerals will carry out drilling to find a source of industrial water, which is essential for direct lithium extraction at Pocitos project within the Rincon JV.
Tech-centric Bailador delivers strong FY25
Tech-centric capital fund Bailador Technology Investments delivers standout FY25, driven by strategic capital deployment and strong growth across its private portfolio.
Prescient advances cancer drug to unlock value
Prescient Therapeutics is entering a critical stage with clinical progress, regulatory tailwinds and commercial opportunity converging.
NVA gets critical show of support for Estelle
Nova Minerals has strengthened ties with key Alaskan lawmakers and other stakeholders during a board visit to its 9.9Moz Estelle gold and critical minerals project.
CMG enters mobility market as joint health interest accelerates
As listed players like Vita Life Sciences and EZZ chase wellness demand, Complementary Medicines Group is stepping up with a clinically backed supplement targeting one of Australia’s most common pain points.
OCT eyes Tasmanian copper-silver-zinc play
Octava Minerals has an option to acquire the Federation copper-silver-zinc project in Tasmania where historical drilling returned significant intersections.
FDA clinical hold lift closer for Neurizon
Neurizon submits a formal response to the US FDA addressing a clinical hold on its investigational new drug (IND) application for lead drug NUZ-001.
Long Shortz: GTI Energy
GTI Energy is almost set to start drilling its in-situ recovery uranium project in Wyoming as demand for yellowcake in the US grows.
Stock Tips: expert makes a Sigma call
Every Sunday our experts deliver their buys, holds and sells. Up today, Baker Young Limited’s Toby Grimm and Ord Minnett’s Tony Paterno.
Original URL: https://www.thechronicle.com.au/business/stockhead/page/5